142 related articles for article (PubMed ID: 9788258)
21. Expression and localization of HGF and met in Wilms' tumours.
Alami J; Williams BR; Yeger H
J Pathol; 2002 Jan; 196(1):76-84. PubMed ID: 11748645
[TBL] [Abstract][Full Text] [Related]
22. Expression and localization of hepatocyte growth factor and its receptor c-Met in inverted papillomas.
Choi JH; Lee SH; Lee HM; Lee SH; Jung HH; Choi J; Lim HW; Lee SW; Kang SM
Acta Otolaryngol; 2006 Jul; 126(7):724-9. PubMed ID: 16803712
[TBL] [Abstract][Full Text] [Related]
23. Myeloma-derived extracellular vesicles mediate HGF/c-Met signaling in osteoblast-like cells.
Strømme O; Psonka-Antonczyk KM; Stokke BT; Sundan A; Arum CJ; Brede G
Exp Cell Res; 2019 Oct; 383(1):111490. PubMed ID: 31283912
[TBL] [Abstract][Full Text] [Related]
24. [Expressions of MACC1, HGF, and C-met protein in epithelial ovarian cancer and their significance].
Zhang RT; Shi HR; Huang HL; Chen ZM; Liu HN; Yuan ZF
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Sep; 31(9):1551-5. PubMed ID: 21945764
[TBL] [Abstract][Full Text] [Related]
25. L-type amino acid transporter-1 and CD98 expression in bone and soft tissue tumors.
Koshi H; Sano T; Handa T; Yanagawa T; Saitou K; Nagamori S; Kanai Y; Takagishi K; Oyama T
Pathol Int; 2015 Sep; 65(9):460-7. PubMed ID: 26134029
[TBL] [Abstract][Full Text] [Related]
26. Expression of the hepatocyte growth factor and c-met in normal thyroid, non-neoplastic, and neoplastic nodules.
Trovato M; Villari D; Bartolone L; Spinella S; Simone A; Violi MA; Trimarchi F; Batolo D; Benvenga S
Thyroid; 1998 Feb; 8(2):125-31. PubMed ID: 9510120
[TBL] [Abstract][Full Text] [Related]
27. Expression of stem cell factor and lack of c-kit expression in malignant fibrous histiocytoma of soft tissues.
Yamamoto T; Nakatani T; Marui T; Akisue T; Fujita I; Matsumoto K; Hitora T; Kawamoto T; Nagira K; Kurosaka M
Anticancer Res; 2003; 23(5b):4305-8. PubMed ID: 14666642
[TBL] [Abstract][Full Text] [Related]
28. Expression of hepatocyte growth factor/scatter factor and its receptor c-Met in brain tumors: evidence for a role in progression of astrocytic tumors (Review).
Moriyama T; Kataoka H; Koono M; Wakisaka S
Int J Mol Med; 1999 May; 3(5):531-6. PubMed ID: 10202187
[TBL] [Abstract][Full Text] [Related]
29. Adaptor molecule Crk is required for sustained phosphorylation of Grb2-associated binder 1 and hepatocyte growth factor-induced cell motility of human synovial sarcoma cell lines.
Watanabe T; Tsuda M; Makino Y; Ichihara S; Sawa H; Minami A; Mochizuki N; Nagashima K; Tanaka S
Mol Cancer Res; 2006 Jul; 4(7):499-510. PubMed ID: 16849525
[TBL] [Abstract][Full Text] [Related]
30. Invasion of retinal pigment epithelial cells: N-cadherin, hepatocyte growth factor, and focal adhesion kinase.
Van Aken EH; De Wever O; Van Hoorde L; Bruyneel E; De Laey JJ; Mareel MM
Invest Ophthalmol Vis Sci; 2003 Feb; 44(2):463-72. PubMed ID: 12556370
[TBL] [Abstract][Full Text] [Related]
31. Expression of hepatocyte growth factor and c-Met in the anterior horn cells of the spinal cord in the patients with amyotrophic lateral sclerosis (ALS): immunohistochemical studies on sporadic ALS and familial ALS with superoxide dismutase 1 gene mutation.
Kato S; Funakoshi H; Nakamura T; Kato M; Nakano I; Hirano A; Ohama E
Acta Neuropathol; 2003 Aug; 106(2):112-20. PubMed ID: 12707786
[TBL] [Abstract][Full Text] [Related]
32. Expression of hepatocyte growth factor and its receptor c-met in human leukemia-lymphoma cell lines.
Pons E; Uphoff CC; Drexler HG
Leuk Res; 1998 Sep; 22(9):797-804. PubMed ID: 9716011
[TBL] [Abstract][Full Text] [Related]
33. Filamin a mediates HGF/c-MET signaling in tumor cell migration.
Zhou AX; Toylu A; Nallapalli RK; Nilsson G; Atabey N; Heldin CH; Borén J; Bergo MO; Akyürek LM
Int J Cancer; 2011 Feb; 128(4):839-46. PubMed ID: 20473907
[TBL] [Abstract][Full Text] [Related]
34. Hepatocyte growth factor and its receptor (c-MET) in prostatic carcinoma.
Humphrey PA; Zhu X; Zarnegar R; Swanson PE; Ratliff TL; Vollmer RT; Day ML
Am J Pathol; 1995 Aug; 147(2):386-96. PubMed ID: 7639332
[TBL] [Abstract][Full Text] [Related]
35. Hepatocyte growth factor (HGF), HGF activator, and c-Met in synovial tissues in rheumatoid arthritis and osteoarthritis.
Nagashima M; Hasegawa J; Kato K; Yamazaki J; Nishigai K; Ishiwata T; Asano G; Yoshino S
J Rheumatol; 2001 Aug; 28(8):1772-8. PubMed ID: 11508578
[TBL] [Abstract][Full Text] [Related]
36. Aberrant expression of hepatocyte growth factor and its receptor, c-Met, during sex hormone-induced prostatic carcinogenesis in the Noble rat.
Tam NN; Chung SS; Lee DT; Wong YC
Carcinogenesis; 2000 Dec; 21(12):2183-91. PubMed ID: 11133807
[TBL] [Abstract][Full Text] [Related]
37. Involvement of hepatocyte growth factor in the development of bone metastasis of a mouse mammary cancer cell line, BALB/c-MC.
Ono K; Kamiya S; Akatsu T; Nakamura C; Li M; Amizuka N; Matsumoto K; Nakamura T; Kugai N; Wada S
Bone; 2006 Jul; 39(1):27-34. PubMed ID: 16459153
[TBL] [Abstract][Full Text] [Related]
38. Malignant fibrous histiocytoma of soft tissue: an abandoned diagnosis.
Randall RL; Albritton KH; Ferney BJ; Layfield L
Am J Orthop (Belle Mead NJ); 2004 Dec; 33(12):602-8. PubMed ID: 15641745
[TBL] [Abstract][Full Text] [Related]
39. Targeting the Hepatocyte Growth Factor and c-Met Signaling Axis in Bone Metastases.
Whang YM; Jung SP; Kim MK; Chang IH; Park SI
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30658428
[TBL] [Abstract][Full Text] [Related]
40. [Immunohistochemical study of malignant fibrous histiocytoma].
Pozharisskiĭ KM; Nikitin AIu
Arkh Patol; 1987; 49(8):11-6. PubMed ID: 2823748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]